PER® Annual Live Medical Crossfire: Hematologic Malignancies | Conference

Experts Explore Treatment Approaches With Novel Agents in ALL

July 11th 2020

A panel of experts in acute lymphoblastic leukemia broach the topic of innovative approaches incorporating novel agents in clinical practice.

Panel of Experts Cover Clinical Scenarios in AML

July 11th 2020

A panel of experts in acute myeloid leukemia (AML) consider potential treatment options for patients with AML

CML Experts Consider Challenging Cases Faced in Clinical Practice

July 11th 2020

A panel of experts in chronic myeloid leukemia share insight on how to optimally approach treatment based on patient characteristics.

Dr. Raje on Key Challenges Faced in Multiple Myeloma

July 11th 2020

Noopur Raje, MD, discusses the current challenges faced in the multiple myeloma treatment paradigm.

Dr. Leslie on Remaining Questions to Address in MCL

July 11th 2020

Lori Leslie, MD, discusses key questions to address with future research efforts in mantle cell lymphoma.

Dr. Hobbs on the Updated NCCN Guidelines in CML

July 20th 2018

Gabriela S. Hobbs, MD, clinical director, Leukemia Service, assistant in medicine, Massachusetts General Hospital, discusses the updated NCCN guidelines in chronic myeloid leukemia (CML).

Dr. Brander on the Treatment Landscape for Patients With High-Risk CLL

July 20th 2018

Danielle Marie Brander, MD, assistant professor of medicine, Duke Cancer Institute, discusses the treatment landscape for patients with high-risk chronic lymphocytic leukemia (CLL).

Expert Shares Insights on CLL Treatment Paradigm

July 20th 2018

Jacqueline D. Barrientos, MD, MS, discusses the current treatment landscape for CLL, highlights some of the biggest challenges for physicians, and gives her insight on how to move forward in the field.

Immunotherapy at the Forefront of ALL Treatment, Expert Says

July 20th 2018

Major advancements in immunotherapy are at the forefront of treatment for patients with acute lymphoblastic leukemia.

Immunotherapy Treatment Options Continue to Grow in Relapsed/Refractory Multiple Myeloma

July 20th 2018

Sham Mailankody, MBBS, discusses current treatment options and shifting preferences, especially toward triplet combinations, as well as emerging immunotherapy treatment options in multiple myeloma.

Dr. Pinilla-Ibarz Discusses Advancements in CML

July 16th 2018

Javier A. Pinilla-Ibarz, MD, PhD senior member, Moffit Cancer Center, discusses the recent advances in chronic myeloid leukemia (CML). Pinilla-Ibarz says that he and colleagues do not expect much in the field after other recent advancements, but he is still surprised to see what is being concentrated on today.

Dr. Madduri on SWOG S0777 in Multiple Myeloma

July 16th 2018

Deepu Madduri, MD, assistant professor, Mount Sinai Hospital, discusses evidence supporting the use of a triplet regimen versus a doublet regimen in elderly and transplant ineligible patients with multiple myeloma.

Despite New Treatments in CLL, Comparative Data and Guidance Slow to Emerge

July 15th 2018

With newer agents approved for patients with chronic lymphocytic leukemia, physicians are now challenged with how best to utilize them.

Pembrolizumab Data Reviewed in Classical Hodgkin Lymphoma

July 15th 2018

George F. Geils, Jr, MD, discussed the clinical efficacy and adverse event management techniques for pembrolizumab as a treatment for patients with classical Hodgkin lymphoma.

CAR T-cell Therapies Offer Hope for DLBCL

July 15th 2018

Chimeric antigen receptor T-cell therapies have quickly moved from early phase clinical trials to FDA approval for diffuse large B-cell lymphoma, with research now exploring ways to shift these agents earlier in the treatment paradigm.

Expert Discusses the Discontinuation of TKIs in Treatment Landscape of CML

July 14th 2018

Gabriela S. Hobbs, MD, discusses how discontinuing tyrosine kinase inhibitors will change the treatment landscape and other strategies for treating patients with chronic myeloid leukemia.

Dr. Barrientos on the Challenges in CLL

July 14th 2018

Jacqueline D. Barrientos, MD, MS, CLL Research and Treatment Program, Northwell Health Systems, discusses the current challenges oncologists are faced with in the field of chronic lymphocytic leukemia.

Dr. Lesokhin Discusses Exciting Advances in Multiple Myeloma

July 14th 2018

Alexander M. Lesokhin, MD, assistant attending, Department of Medicine and Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses some of the exciting advancements currently happening in the field of multiple myeloma.